Eseroline

An opioid agonist structurally related to physostigmine (eserine) and morphine. Metabolite of Physostigmine/Eserine. A portion of administered cymserine is metabolized in the body into eseroline, a potent mu opioid agonist and neurotoxin

General

Type : Derivative of physostigmine-eserine, Indole

Chemical_Nomenclature : (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8 trimethylpyrrolo[2,3-b]indo l-5-ol

Canonical SMILES : CC12CCN(C1N(C3=C2C=C(C=C3)O)C)C

InChI : InChI=1S\/C13H18N2O\/c1-13-6-7-14(2)12(13)15(3)11-5-4-9(16)8-10(11)13\/h4-5,8,12,16H,6-7H2,1-3H3 || InChI=1S\/C13H18N2O\/c1-13-6-7-14(2)12(13)15(3)11-5-4-9(16)8-10(11)13\/h4-5,8,12,16H,6-7H2,1-3H3\/t12-,13+\/m1\/s1

InChIKey : HKGWQUVGHPDEBZ-UHFFFAOYSA-N || HKGWQUVGHPDEBZ-OLZOCXBDSA-N

Other name(s) : CHEMBL310934  ||  CHEBI:48845  ||  ST057526  ||  (3as-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol  ||  STK683285  ||  AC1Q7A0V  ||  SCHEMBL150459  ||  AC1L1B22  ||  CHEMBL2322559


MW : 218.295

Formula : C13H18N2O

CAS_number : 469-22-7

PubChem : 1250,    119198

UniChem : HKGWQUVGHPDEBZ-UHFFFAOYSA-N,    HKGWQUVGHPDEBZ-OLZOCXBDSA-N

Wikipedia : Eseroline

Target

Families : Eseroline ligand of proteins in family
ACHE

References (9)

Title : Reversible inhibition of cholinesterases by opioids: possible pharmacological consequences - Galli_1996_J.Pharm.Pharmacol_48_1164
Author(s) : Galli A , Ranaudo E , Giannini L , Costagli C
Ref : J Pharm Pharmacol , 48 :1164 , 1996
Abstract :
PubMedSearch : Galli_1996_J.Pharm.Pharmacol_48_1164
PubMedID: 8961166

Title : Eseroline, a metabolite of physostigmine, induces neuronal cell death - Somani_1990_Toxicol.Appl.Pharmacol_106_28
Author(s) : Somani SM , Kutty RK , Krishna G
Ref : Toxicol Appl Pharmacol , 106 :28 , 1990
Abstract :
PubMedSearch : Somani_1990_Toxicol.Appl.Pharmacol_106_28
PubMedID: 2251681

Title : Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration - Somani_1989_Biopharm.Drug.Dispos_10_187
Author(s) : Somani SM
Ref : Biopharmaceutics & Drug Disposition , 10 :187 , 1989
Abstract :
PubMedSearch : Somani_1989_Biopharm.Drug.Dispos_10_187
PubMedID: 2706318

Title : Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases - Atack_1989_J.Pharmacol.Exp.Ther_249_194
Author(s) : Atack JR , Yu QS , Soncrant TT , Brossi A , Rapoport SI
Ref : Journal of Pharmacology & Experimental Therapeutics , 249 :194 , 1989
Abstract :
PubMedSearch : Atack_1989_J.Pharmacol.Exp.Ther_249_194
PubMedID: 2709330

Title : Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase - Yu_1988_FEBS.Lett_234_127
Author(s) : Yu QS , Atack JR , Rapoport SI , Brossi A
Ref : FEBS Letters , 234 :127 , 1988
Abstract :
PubMedSearch : Yu_1988_FEBS.Lett_234_127
PubMedID: 3391264

Title : Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration - Somani_1987_Drug.Metab.Dispos_15_627
Author(s) : Somani SM , Khalique A
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 15 :627 , 1987
Abstract :
PubMedSearch : Somani_1987_Drug.Metab.Dispos_15_627
PubMedID: 2891478

Title : Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration - Somani_1986_Fundam.Appl.Toxicol_6_327
Author(s) : Somani SM , Khalique A
Ref : Fundamental & Applied Toxicology , 6 :327 , 1986
Abstract :
PubMedSearch : Somani_1986_Fundam.Appl.Toxicol_6_327
PubMedID: 3699321

Title : In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates - Galli_1985_J.Pharm.Pharmacol_37_42
Author(s) : Galli A , Malmberg-Aiello P , Renzi G , Bartolini A
Ref : J Pharm Pharmacol , 37 :42 , 1985
Abstract :
PubMedSearch : Galli_1985_J.Pharm.Pharmacol_37_42
PubMedID: 2858526

Title : Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine - Galli_1982_Biochem.Pharmacol_31_1233
Author(s) : Galli A , Renzi G , Grazzini E , Bartolini R , Malmberg-Aiello P , Bartolini A
Ref : Biochemical Pharmacology , 31 :1233 , 1982
Abstract :
PubMedSearch : Galli_1982_Biochem.Pharmacol_31_1233
PubMedID: 7092918